BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

772 related articles for article (PubMed ID: 15239341)

  • 1. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C
    Bull Cancer; 2004 May; 91 Spec No():S125-31. PubMed ID: 15239341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analgesic effects of cyclooxygenase 2 inhibitors].
    Jayr C
    Bull Cancer; 2004 May; 91 Suppl 2():S125-31. PubMed ID: 15899637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxibs: Evolving role in pain management.
    Katz N
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):15-24. PubMed ID: 12528070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
    Stephens J; Laskin B; Pashos C; Peña B; Wong J
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibitors: new drugs for the management of pain and inflammation.
    Hutchins V; Hutchins B
    Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclo-oxygenase 2 inhibitors: an important new drug classification.
    Kessenich CR
    Pain Manag Nurs; 2001 Mar; 2(1):13-8. PubMed ID: 11705156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The coxibs, third generation anti-inflammatories].
    Sternon J
    Rev Med Brux; 2001 Apr; 22(2):100-5. PubMed ID: 11388024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances].
    Hinz B; Brune K
    Wien Klin Wochenschr; 1999 Feb; 111(3):103-12. PubMed ID: 10093892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?].
    Hinz B; Brune K
    MMW Fortschr Med; 2000 Mar; 142(11):39-40. PubMed ID: 10786088
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on specific COX-2 inhibitors: the COXIBs.
    Gupta S; Crofford LJ
    Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyclooxygenase-2 inhibitors in postoperative pain management].
    Güneş Y; Işik G
    Agri; 2004 Jul; 16(3):7-16. PubMed ID: 15382000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
    Bensen WG
    J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2 inhibitors.
    Brooks PM; Day RO
    Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain management in osteoarthritis: the role of COX-2 inhibitors.
    Lane NE
    J Rheumatol Suppl; 1997 Jul; 49():20-4. PubMed ID: 9249647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.